Altitude Crest Partners »

Surrozen shares owned by Altitude Crest Partners

Quarter-by-quarter ownership of Surrozen (SRZNW) shares owned by Altitude Crest Partners from 13F filings

Historical chart of Altitude Crest Partners investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Altitude Crest Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Altitude Crest Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.7k 385k 0.02

More positions owned by Altitude Crest Partners

Legend Biotech Corp Sponsored Ads (LEGN)
Bridgebio Pharma (BBIO)
Danaher Corporation (DHR)
Argenx Se Sponsored Adr (ARGX)
BioMarin Pharmaceutical (BMRN)
Apellis Pharmaceuticals (APLS)
Roivant Sciences SHS (ROIV)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
EXACT Sciences Corporation (EXAS)
Aligos Therapeutics (ALGS)
Ambrx Biopharma
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for Altitude Crest Partners

Top funds holding Surrozen

Baker Bros. Advisors
LMR Partners
Bridger Management
Altitude Crest Partners
Euclidean Capital
Deerfield Management Company
Perceptive Advisors
Arrowpoint Asset Management
Samsara BioCapital
Millennium Management
Boxer Capital
EcoR1 Capital
Cantor Fitzgerald, L. P.
Highbridge Capital Management
Cowen And Company

View all funds holding Surrozen